Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
USCB vs CZNC vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
USCB vs CZNC vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $357M | $395M | $896.00B |
| Revenue (TTM) | $152M | $165M | $280.33B |
| Net Income (TTM) | $26M | $17M | $57.05B |
| Gross Margin | 58.1% | 59.4% | 60.0% |
| Operating Margin | 23.6% | 12.9% | 25.9% |
| Forward P/E | 9.8x | 11.2x | 14.4x |
| Total Debt | $91M | $193M | $942.38B |
| Cash & Equiv. | $82M | $46M | $343.34B |
USCB vs CZNC vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | Jun 26 | Return |
|---|---|---|---|
| USCB Financial Hold… (USCB) | 100 | 183.6 | +83.6% |
| Citizens & Northern… (CZNC) | 100 | 89.3 | -10.7% |
| JPMorgan Chase & Co. (JPM) | 100 | 211.3 | +111.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: USCB vs CZNC vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
USCB is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 5.6%, EPS growth 4.8%
- PEG 0.38 vs CZNC's 4.47
- NIM 3.0% vs JPM's 2.2%
CZNC has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.47, yield 4.6%
- Lower volatility, beta 0.47, Low D/E 56.5%, current ratio 1.11x
- Beta 0.47, yield 4.6%, current ratio 1.11x
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs USCB's 88.5%
- Efficiency ratio 0.3% vs CZNC's 0.5% (lower = leaner)
- Efficiency ratio 0.3% vs CZNC's 0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.6% NII/revenue growth vs CZNC's -0.8% | |
| Value | Lower P/E (9.8x vs 14.4x), PEG 0.38 vs 0.81 | |
| Quality / Margins | Efficiency ratio 0.3% vs CZNC's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.47 vs JPM's 0.94, lower leverage | |
| Dividends | 4.6% yield, vs JPM's 1.9% | |
| Momentum (1Y) | +23.0% vs USCB's +20.6% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs CZNC's 0.5% |
USCB vs CZNC vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
USCB vs CZNC vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 1843.3x USCB's $152M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CZNC's 10.5%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $152M | $165M | $280.3B |
| EBITDAEarnings before interest/tax | $36M | $22M | $81.4B |
| Net IncomeAfter-tax profit | $26M | $17M | $57.0B |
| Free Cash FlowCash after capex | $43M | $36M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +58.1% | +59.4% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +23.6% | +12.9% | +25.9% |
| Net MarginNet income ÷ Revenue | +17.2% | +10.5% | +20.4% |
| FCF MarginFCF ÷ Revenue | +27.9% | +22.0% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -79.4% | -96.2% | +16.0% |
Valuation Metrics
USCB leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 15.0x trailing earnings, USCB trades at a 6% valuation discount to JPM's 16.0x P/E. Adjusting for growth (PEG ratio), USCB offers better value at 0.58x vs CZNC's 6.03x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $357M | $395M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $365M | $542M | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 15.04x | 15.11x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.76x | 11.20x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 0.58x | 6.03x | 0.90x |
| EV / EBITDAEnterprise value multiple | 10.04x | 18.93x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 2.35x | 2.56x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.69x | 1.03x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 8.40x | 13.13x | 8.88x |
Profitability & Efficiency
USCB leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $6 for CZNC. USCB carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), USCB scores 6/9 vs JPM's 5/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +11.9% | +5.5% | +15.9% |
| ROA (TTM)Return on assets | +1.0% | +0.6% | +1.3% |
| ROICReturn on invested capital | +7.8% | +4.2% | +4.5% |
| ROCEReturn on capital employed | +10.8% | +1.6% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.43x | 0.56x | 2.60x |
| Net DebtTotal debt minus cash | $8M | $147M | $599.0B |
| Cash & Equiv.Liquid assets | $82M | $46M | $343.3B |
| Total DebtShort + long-term debt | $91M | $193M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.58x | 0.45x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $11,108 for CZNC. Over the past 12 months, CZNC leads with a +23.0% total return vs USCB's +20.6%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CZNC's 7.2% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +8.8% | +13.3% | -0.5% |
| 1-Year ReturnPast 12 months | +20.6% | +23.0% | +21.8% |
| 3-Year ReturnCumulative with dividends | +97.7% | +23.3% | +138.2% |
| 5-Year ReturnCumulative with dividends | +88.5% | +11.1% | +118.2% |
| 10-Year ReturnCumulative with dividends | +88.5% | +62.1% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +25.5% | +7.2% | +33.6% |
Risk & Volatility
Evenly matched — CZNC and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
CZNC is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs CZNC's 91.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.70x | 0.47x | 0.94x |
| 52-Week HighHighest price in past year | $20.79 | $24.11 | $337.25 |
| 52-Week LowLowest price in past year | $15.57 | $18.16 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +94.1% | +91.5% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 63.2 | 57.3 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 58K | 39K | 7.0M |
Analyst Outlook
Evenly matched — CZNC and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: USCB as "Buy", CZNC as "Hold", JPM as "Buy". Consensus price targets imply 22.8% upside for USCB (target: $24) vs 5.9% for JPM (target: $340). For income investors, CZNC offers the higher dividend yield at 4.63% vs JPM's 1.86%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $24.00 | $23.50 | $339.75 |
| # AnalystsCovering analysts | 3 | 1 | 61 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +4.6% | +1.9% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 15 |
| Dividend / ShareAnnual DPS | $0.43 | $1.02 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.7% | +0.1% | +3.9% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). USCB leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
USCB vs CZNC vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is USCB or CZNC or JPM a better buy right now?
For growth investors, USCB Financial Holdings, Inc.
(USCB) is the stronger pick with 5. 6% revenue growth year-over-year, versus -0. 8% for Citizens & Northern Corporation (CZNC). USCB Financial Holdings, Inc. (USCB) offers the better valuation at 15. 0x trailing P/E (9. 8x forward), making it the more compelling value choice. Analysts rate USCB Financial Holdings, Inc. (USCB) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — USCB or CZNC or JPM?
On trailing P/E, USCB Financial Holdings, Inc.
(USCB) is the cheapest at 15. 0x versus JPMorgan Chase & Co. at 16. 0x. On forward P/E, USCB Financial Holdings, Inc. is actually cheaper at 9. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: USCB Financial Holdings, Inc. wins at 0. 38x versus Citizens & Northern Corporation's 4. 47x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — USCB or CZNC or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +11. 1% for Citizens & Northern Corporation (CZNC). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CZNC's +62. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — USCB or CZNC or JPM?
By beta (market sensitivity over 5 years), Citizens & Northern Corporation (CZNC) is the lower-risk stock at 0.
47β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 99% more volatile than CZNC relative to the S&P 500. On balance sheet safety, USCB Financial Holdings, Inc. (USCB) carries a lower debt/equity ratio of 43% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — USCB or CZNC or JPM?
By revenue growth (latest reported year), USCB Financial Holdings, Inc.
(USCB) is pulling ahead at 5. 6% versus -0. 8% for Citizens & Northern Corporation (CZNC). On earnings-per-share growth, the picture is similar: USCB Financial Holdings, Inc. grew EPS 4. 8% year-over-year, compared to -13. 6% for Citizens & Northern Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — USCB or CZNC or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 15. 2% for Citizens & Northern Corporation — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 18. 6% for CZNC. At the gross margin level — before operating expenses — CZNC leads at 65. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is USCB or CZNC or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, USCB Financial Holdings, Inc. (USCB) is the more undervalued stock at a PEG of 0. 38x versus Citizens & Northern Corporation's 4. 47x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, USCB Financial Holdings, Inc. (USCB) trades at 9. 8x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 4. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USCB: 22. 8% to $24. 00.
08Which pays a better dividend — USCB or CZNC or JPM?
All stocks in this comparison pay dividends.
Citizens & Northern Corporation (CZNC) offers the highest yield at 4. 6%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is USCB or CZNC or JPM better for a retirement portfolio?
For long-horizon retirement investors, Citizens & Northern Corporation (CZNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
47), 4. 6% yield). Both have compounded well over 10 years (CZNC: +62. 1%, USCB: +88. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between USCB and CZNC and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.